Covid19 Impact on Diagnostic Electrocardiograph (ECG) Market Perspective With Study Of Key Players & Revenue To Steady Growth Forecast To 2023

 The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height. 

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393

According to Market Research Future (MRFR), the global Artificial Intelligence (AI) in Drug Discovery Market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes. 

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery. 

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market. 

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics;

By Product Type    : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology       : Machine Learning, Deep Learning, and others.

By Indication          : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application       : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User            : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions               : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

 

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth.

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market.

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market.

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket.

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI in drug discovery market . It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

AI in Drug Discovery Market   - Competitive Analysis

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.  

Browse Complete Report @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

 

Major Players: 

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others. 

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:       

Akash Anand           

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Artificial intelligence (AI) in Drug Discovery Market Reflect Enormous Growth at a CAGR 40.8% by 2025

 The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height. 

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393

According to Market Research Future (MRFR), the global Artificial Intelligence (AI) in Drug Discovery Market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes. 

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery. 

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market. 

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics;

By Product Type    : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology       : Machine Learning, Deep Learning, and others.

By Indication          : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application       : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User            : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions               : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

 

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth.

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market.

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market.

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket.

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI in drug discovery market . It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

AI in Drug Discovery Market   - Competitive Analysis

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.  

Browse Complete Report @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

 

Major Players: 

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others. 

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:       

Akash Anand           

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Healthcare Contract Manufacturing Market Demand By Top Companies - Global Analysis to Forecast by 2023

 Market Insights 

A globally growing population and a gradually transforming healthcare sector are witnessing the growth in the healthcare contract manufacturing market. Valued a USD 129.91 billion at the end of 2016, the global Healthcare CMO Market is expected to grow at an above average CAGR of 9.86% during the forecast period of 2017 to 2023. 

The global healthcare sector is undergoing some major changes as new technologies, and various other factors make their mark. The patent expiry of various popular drugs and medical devices is encouraging new players to enter the market, thus increasing competition. Subsequently, the increased competition has compelled leading market players to reform their existing business strategies in order to perpetuate further market growth. In response to growing expenses on R & D and the increased focus of major player on various other core strategies, have boosted the market for healthcare contract manufacturing organizations (CMOs). Additionally, the global demand for effective drugs and medical devices has grown substantially, and in order to meet these demands successfully, major players are turning to contract manufacturing. Emerging economies are expected to be vital in the future of this market due to the high concentration of expertise and increasingly available research & development technologies. These countries offer lower operating costs, comparatively cheap, experienced labor and supportive government bodies that aim to improve the regional healthcare sector. The sanction of Good Manufacturing Practice certificates in emerging economies has contributed considerably to the growth of the healthcare contract manufacturing market. 

The growing cost of R&D and the complexity of the supply chain combined with difficulties regarding control of 3rd parties may hinder market growth during the forecast period. However, the need for product innovation, the growing outsourcing of various other activities such as design, feasibility tests, and validation are expected to provide ample opportunity for growth of the market in the coming years.

Market Segmentation

The global healthcare contract manufacturing market is segmented on the basis of type, service type, industry, and region. By type, the market is segmented into sterile, and nonsterile.The nonsterile segment is growing at the most significant pace and is expected to achieve a CAGR of 10% during the forecast period due to the reduced standards associated with non-sterile contact manufacturing. By service type, the market is segmented into pharmaceutical contract manufacturing services and medical device contract manufacturing services. By industry, the market is segmented into pharmaceutical, medical device, and biopharmaceutical. By region, the global market is segmented into the Americas, Europe, the Asia-Pacific and the Middle East & Africa.

Regional Analysis

The Americas have the most significant share of the global market due to the increased investment in the healthcare sector in this region, particularly in the U.S and Canada. These countries lead the region's growth and have strong economic conditions. The focus of adoption of the latest in technology and the growing demand for effective treatments have to lead to the sophisticated production of pharmaceuticals and medical devices. The use of advanced manufacturing technology and implementation of cost-effective manufacturing models have propelled the region into leading position. The region is expected to reach an estimated USD 102.99 billion by the end of 2023.

Meanwhile, the Asia-Pacific is the fastest growing regional market and is expected to witness a CAGR of 9.97% during the forecast period. The concentration of emerging economies in this region and supportive policies in this region regarding contract manufacturing organizations is expected to encourage growth for the region during the assessment period. The availability of comparatively cheap labor, a supportive structure for R&D activities and the overall reduced operating costs in emerging economies of this region are some key drivers of growth for the healthcare contract manufacturing market.

Key Players

Prominent players that have been analysed in the report include market leaders such as Evonik Industries, Teva Pharmaceutical Industries, Vetter Pharma International, Mylan, Patheon, Sanmina Corporation, Forefront Medical Technologies, Hamilton Company, Flex Ltd., AbbVie, Boehringer Ingelheim, Lonza AG, Catalan, Aesica Pharmaceuticals, Benchmark Electronics, Grifols International S.A., and others.

Latest Industry News

AstraZeneca and Saudi Pharmaceutical Industries & Medical Appliances  Corporations (SPIMACO) have signed an agreement which initiates the launch of the contract manufacturing operation in the KSA.

Orgenisis, a contract manufacturer for advanced cell therapies, has formed a partnership with Great Point Partners, in order to finance and expand Orgenisis contract development business under a newly formed subsidiary called Masthercell Global.

Read More @ https://www.marketresearchfuture.com/reports/healthcare-contract-manufacturing-market-5637

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Key Trends On Global Ligation Devices Market forecast to 2023

Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024 

Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.

The global ligation devices market trends is expected to register a CAGR of 6.7% during the forecast period of 2019 to 2024.

Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 

Regional Analysis

The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.

In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.

On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.

Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.
On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

…..

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/ligation-devices-market-7794

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

news: Smart insulin pens Market Trends, Analysis, Global demand and forecast

Smart insulin pens are devices used to deliver the accurate dose of insulin to diabetics at the appropriate time. They have gained traction among diabetics due to its simplistic nature and easy to handle mechanism compared to traditional syringes. The global smart insulin pens market report by Market Research Future (MRFR) contains the pertinent drivers and challenges faced by manufacturers during the period of 2018 to 2023.

Smart Insulin Pens Market Overview

The global smart insulin pens market is expected to exhibit 10.4% CAGR during the forecast period (2018-2023) due to high prevalence of diabetes. Furthermore, the use of these devices for the management of diabetes by the general populace in developing countries can bode well for the market during the forecast period. Awareness of advanced drug delivery methods, need for modern treatments, and the alarming cases of diabetes can bolster the global market demand till 2023.

Get Free Sample Copy With Covid19 Impact@https://www.marketresearchfuture.com/sample_request/6789

The surge in the adoption rate of glucose monitoring devices, awareness of these devices, and integration of glucose measurement devices are other drivers of the market. According to the World Health Organization (WHO), diabetes was accountable for 1.2 million deaths in 2012. This can spark the demand for smart insulin pens for proper management of diabetes. Co-pay assistance and medical reimbursement policies covering the purveying of these devices can ensure the continuous sales.

Unfavorable reimbursement policies, risks associated with insulin pens, and increasing costs of insulin pens are challenges faced by the market.

Smart Insulin Pens Market Segmentation

The global smart insulin pens market has been segmented on the basis of product type, usability, and distribution channel.

On the basis of product type, the market has been segmented into first-generation pens and second-generation pens. The second-generation pens segment has been further divided into Bluetooth-enabled and USB connected.

By usability, the segment has been divided into disposable pens and reusable pens. Reusable insulin pens segment is likely to be the fastest growing segment during the forecast period.

The market, by distribution channel, has been segmented into retail pharmacies, diabetes clinics, online medical stores, and hospital pharmacies.

Smart Insulin Pens Market Regional Analysis

The Middle East & Africa (MEA), Americas, Asia Pacific (APAC), and Europe are regions discussed in the global smart insulin pens market report.

The Americas can be the leading region of the global market till 2023 due to favorable policies by regulatory authorities, adoption of advanced technology, and rising prevalence of diabetes among the general populace. The approval of novel injectable devices by regulatory agencies can drive the global smart insulin pens market growth.

The Europe smart insulin pens market is driven by adoption of advanced drug delivery devices, rising cases of diabetics, and presence of major players. According to the World Diabetes Foundation, more than 59 million have been diagnosed with diabetes, with the number purported to touch 71.1 million by 2040.

Government policies for assisting diabetics and rise in disposable income levels of patients are main drivers of the smart insulin pens market in APAC. Large cases of diabetes recorded in Southeast Asia can drive the regional market growth. As per the International Diabetes Federation, the number of diabetics in the region can touch 156 million by 2045.

Competition Outlook

InjexUK, Lilly USA, LLC, Digital Medics Pty Ltd., Companion Medical, Sanofi-Aventis US LLC, Diamesco Co., Ltd., Smith’s Medical, NIPRO Medical Corporation, Novo Nordisk A/S, Biocorp, Emperra GmbH E-Health Technologies, and others are notable players of the global smart insulin pens market. Manufacturers are launching new iterations of smart insulin pens for recording the proper dosage amounts and reminders of taking insulin shots at the appropriate time. For instance, the InPen by Companion Medical can capture mealtime data and shares it on the respective medical mobile application.

Industry News

Recently, Medtronic and Novo Nordisk have decided to pool in their offerings for sharing the data acquired by their smart insulin pens on a common diabetes management platform.

Read More About report@

https://www.marketresearchfuture.com/reports/smart-insulin-pens-market-6789

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Vocal Biomarkers Market to Expand with Significant CAGR During 2018 to 2023

 

Vocal biomarkers are a novel technique developed to detect the presence of disease from speech characteristics. By decoding the vocal intonations in real-time, the technology can provide holistic treatment and quality patient care. The global vocal biomarkers market report by Market Research Future (MRFR) highlights several developments which can assist diseases combined with supporting drivers and restraints for the period of 2017 and 2023 (forecast period).

Get Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3933

Vocal Biomarkers Market Outlook

The global vocal biomarkers market is bound to touch a valuation of USD 2.5 billion by 2023. It can exhibit a CAGR of 14.3% during the forecast period. It is driven the prevalence of various neurological and psychological diseases such as Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, depression, attention deficit and disruptive behavior disorders, traumatic brain injury, and others. According to the WHO, close to 350 million suffered from depression in 2016 and the Parkinson’s disease Foundation estimated the number of patients affected by the disease to be reaching a number of 10 million in the same year.

Various government organizations are partnering up with private clinics and firms to develop machine learning algorithms for initial detection of diseases. This is exemplified by the alliance of American Heart Association with Mayo Clinic and Beyond Verbal to use voice patterns to detect coronary heart disease at its initial stage. Development of smartphone applications to detect all disease from voice or sounds can provide the global vocal biomarkers the much-needed impetus in the coming years.

You can Also Read Here!! https://www.medgadget.com/2019/06/vocal-biomarkers-market-2019-information-by-type-by-indications-by-end-user-global-size-share-analysis-regional-growth-demand-and-business-opportunities.html

Vocal Biomarkers Market Segmentation Analysis

The global vocal biomarkers market is segmented by type, indication, and end-user.

The global market, by type is segmented into pitch, voice tremor, vocal rise or fall time, phonation time, error rate, amplitude, frequency, and others.

The market, by indication, is segmented into neurological disorders, psychiatric disorders, cardiovascular disorders, respiratory disorders, and others.

Based on end-user, the market is segmented into academic and research, hospitals and clinics, and others.

Vocal Biomarkers Market Regional Analysis

The Middle East & Africa (MEA), Americas, Europe, and Asia Pacific (APAC) are major regions in the global vocal biomarkers market.

The Americas is predicted to dominate the global market due to the U.S. grabbing maximum shares owing to large healthcare expenditure and favorable reimbursement schemes. The fast adoption rate of new technology can be pivotal in driving the vocal biomarkers market. Alternatives to MRI/CT/EEG machines will find demand due to the large elderly populace in the region.

Europe is the second-biggest region for the market due to large awareness levels and expendable income levels of patients. In addition, the need for non-invasive techniques for detection of diseases is ensured to gain traction and pave way for the global vocal biomarkers market.

The APAC region is expected to have the largest potential for the market due to the large patient pool in China and India. On the other hand, the MEA region will contribute to the vocal biomarkers market due to the booming medical sector in Saudi Arabia and UAE.

Vocal Biomarkers Market Competitive Outlook

Audio Profiling, Sonde Health, IBM Corporation, Beyond Verbal, Cogito Corporation, and others are reputed companies currently operating in the global vocal biomarkers market.

Industry Update

Sonde Health has managed to raise close to USD 16 million in series A funding to spur the development of vocal biomarkers. The technology has amassed hundreds of vocal characteristics from recordings to identify changes in pitch, rate of speech, and hoarseness to assess health.

Aural Analytics has published the results of a clinical trial involving the effects of reldesemtiv, a skeletal muscle troponin activator, used in the treatment of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). The company analyzed vocal biomarkers for the duration of the trial to notice any improvements in speech patterns.

Read more @ https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

 

Demand On Global Veterinary Pain Management Market Size, Share and Regional Growth by 2027

 Global Veterinary Pain Management Market: Information by Product (Medication (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Local Anesthetics, A2-Adrenergic Agonists, Muscle Relaxants, Sedatives), Route of Administration (Oral, Parental, Topical), Devices (Laser Therapy Devices, Electromagnetic Therapy Devices)), Application (Joint Pain (Osteoarthritis, Musculoskeletal Disorders), Postoperative Pain, Cancer, Others) End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others), Distribution Channel (Hospitals and Clinics, Pharmacies, others) - Forecast till 2027

Market Highlights:
Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.

Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961

Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).

Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.

Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.

Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.

On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.

Veterinary Pain Management Market   - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -

By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.

By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.

By Route of Administration: Oral, Parenteral, and Topical among others. 

By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.

By Application: Joint Pain, Postoperative Pain, and Cancer among others.

By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  

By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Veterinary Pain Management Market   - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 

Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.

Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.

The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.

The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.

Veterinary Pain Management Market   - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.

Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.

Industry/ Innovation/ Related News:

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com